U.S. Markets close in 2 hrs 57 mins

Elekta AB (publ) (EKTAF)

OTC Markets - OTC Markets Delayed Price. Currency in USD
Add to watchlist
9.750.00 (0.00%)
As of 9:44AM EDT. Market open.

Elekta AB (publ)

Box 7593
Stockholm 103 93
Sweden
46 8 58 72 54 00
http://www.elekta.com

Sector
Industry
Full Time Employees3,681

Key Executives

NameTitlePayExercisedAge
Mr. Laurent Leksell Ph.D.(Economics)Founder & Chairman142.47kN/A65
Dr. Richard Hausmann Ph.D.Pres & CEO1.31MN/A57
Mr. Gustaf SalfordCFO & Exec. VPN/AN/A40
Mr. Johan SedihnChief Operating OfficerN/AN/A52
Mr. John LapréChief Technology OfficerN/AN/A53
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Elekta AB (publ) develops and sells clinical solutions for the treatment of cancer and brain disorders worldwide. The company offers Leksell Gamma Knife, a system for cranial stereotactic radiosurgery; the Extend system for utilization of Leksell Gamma Knife Perfexion; and Leksell Stereotactic System for neurosurgery and biopsies. Its neuroscience solutions comprise Gamma Knife radiosurgery for the treatment of brain disorders; stereotactic neurosurgery; and surgical navigation accessories, as well as Elekta Neuromag TRIUX, a magnetoencephalography platform. The company also provides oncology treatment solutions, such as Precise Treatment System, a digital treatment system; Elekta Axesse, a stereotactic radiation therapy system; Elekta Compact, a gateway to RT for oncology centers; Elekta Synergy system that visualizes tumor targets and normal tissue, and their movement between and during fractions; treatment planning systems; oncology information systems solutions; Versa HD, a linear accelerator; and Elekta Infinity system for volumetric arc modulated therapy, as well as various treatment techniques. In addition, it offers brachytherapy solutions that include afterloading platforms; real-time prostate solutions; Oncentra Brachy, a radiotherapy treatment planning system; Esteya for treating skin cancer; and applicators. Further, the company provides software products, including MOSAIQ oncology information system; Oncology Informatics/Data Alliances that streamlines the flow of information in the cancer care team; medical oncology software; Clarity Soft Tissue Visualization, a software for radiation therapy; Monaco, a treatment planning system; Venezia, an applicator for treating gynecological cancer; and METRIQ, a cancer registry data solution. It also offers installation, implementation, training, education, and consultative services. It primarily serves hospitals and academic institutions. The company was founded in 1972 and is headquartered in Stockholm, Sweden.

Corporate Governance

Elekta AB (publ)’s ISS Governance QualityScore as of August 1, 2017 is 8. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 8; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.